Procurement comparison
Comparison: Blue Sky Peptide vs Compliant Research Suppliers
Third-Party CoA Inconsistent (60% of reviewed batches) 100%. Published per batch with ISO 17025 traceability 100%. Required by institutional procurement Blue Sky's gaps would fail institutional audit FDA Registration Status Unregistered. Operated as research c
Review the documented criteria directly; this page does not generate a winner or rating.
- Third-Party CoA
- Inconsistent (60% of reviewed batches)
- 100%. Published per batch with ISO 17025 traceability
- 100%. Required by institutional procurement
- Blue Sky's gaps would fail institutional audit
- FDA Registration Status
- Unregistered. Operated as research chemical vendor
- Registered 503B facility under FDA oversight
- Registered manufacturers or authorised distributors
- Unregistered suppliers face closure risk post-2023
- Customer Verification
- None. Open consumer sales
- Research affiliation verified before high-risk peptide access
- Institutional credentials required
- Open sales model incompatible with current FDA guidance
- Endotoxin Testing
- Not disclosed on CoA
- LAL assay results included in CoA
- Standard for all injectable-grade compounds
- Absence of endotoxin data disqualifies for sterile use
- Price per mg (BPC-157 5mg)
- $28–$35
- $45–$55
- $120–$180 (smaller minimum orders)
- Lower price reflected reduced oversight, not better sourcing